• Inflammation, swelling and pain
• Pressure in joints, blood vessels
• Water retention
• Allergic response
• Rheumatoid arthritis
• Nerve transmission
• Pre-menstrual syndrome
• Vascular disorders
Supplement FactsServing Size:1 Softgel
Gamma linolenic acid (GLA) … 240 mg
Non-medicinal Ingredients: d-alpha-tocopherol (5 IU). Softgel: gelatin (bovine), glycerin.
AOR Guarantees: that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, corn, nuts, dairy, soy, eggs, fish or shellfish.
Source: Borage Oil
What Is It?
Gamma-linolenic acid (GLA) is an omega-6 fatty acid produced in the body from linoleic acid (LA), an essential fatty acid. Although evening primrose oil is the most well-known source of GLA, AOR's GLA-240 is sourced from organic borage oil, because borage contains 2-3 times more GLA than evening primrose oil. This means that each capsule is more cost effective, and fewer capsules need to be consumed in order to get the same amount of GLA.
What Does It Do?
Primary Uses: Although a large imbalance of omega-6 to omega-3 fatty acids is thought to cause inflammation, supplementation with GLA has been shown to have anti-inflammatory effects. One study found that GLA reduced inflammation in patients with rheumatoid arthritis, and GLA has been traditionally used for inflammatory skin conditions such as eczema.
Secondary Uses: GLA has also been demonstrated to improve post-viral fatigue syndrome, mastalgia, diabetic neuropathy, and is thought to provide support during symptoms of PMS and menopause.
Who Should Take It?
GLA is most beneficial for those looking for a healthy, organic source of supplemental essential omega-6 fatty acids and for those who have been prescribed evening primrose oil. It may also benefit those with rheumatoid arthritis and inflammatory skin conditions like eczema.
Take 1 softgel daily with a fat-containing meal, or as directed by a qualified health consultant.
Andreassi M, Forleo P, Di Lorio A, Masci S, Abate G, Amerio P. “
Efficacy of gamma-linolenic acid in the treatment of patients with atopic dermatitis.”
J Int Med Res 1997 Sep-Oct; 25(5): 266-74.
Fearon KC, Falconer JS, Ross JA, Carter DC, Hunter JO, Reynolds PD, Tuffnell Q. “
An open-label phase I/II dose escalation study of the treatment of pancreatic cancer using lithium gammalinolenate.”
Anticancer Res 1996 Mar-Apr; 16(2): 867-74.
Keen H, Payan J, Allawi J, Walker J, Jamal GA, Weir AI, Henderson LM, Bissessar EA, Watkins PJ, Sampson M, et al. “
Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group.”
Diabetes Care 1993 Jan; 16(1): 8-15.
Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH. “
Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis.”
Aging (Milano) 1998 Oct; 10(5): 385.
Puolakka J, Makarainen L, Viinikka L, Ylikorkala O. “
Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors.”
J Reprod Med 1985 Mar; 30(3): 149-53.
Zurier RB, Rossetti RG, Jacobson EW, DeMarco DM, Liu NY, Temming JE, White BM, Laposata M. “
Gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial.”
Arthritis Rheum 1996 Nov; 39(11): 1808-17.
Canada and USA
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.